Drug intelligence / Profile preview

botulinum toxin (Zonguldak Bülent Ecevit University)

Development stage
Unknown
Lead developer
Zonguldak Bülent Ecevit University
Modality
Recombinant Proteins and Enzymes
Administration
Intramuscular
01

Overview

Botulinum toxin is a potent neurotoxic protein produced by the bacterium *Clostridium botulinum* that acts as a neuromuscular blocking agent. It functions by entering peripheral cholinergic nerve terminals and cleaving SNARE proteins, such as SNAP-25, which are essential for the calcium-dependent exocytosis of acetylcholine. This inhibition of neurotransmitter release results in temporary chemical denervation and localized muscle relaxation. In the clinical context of bruxism and masseter hypertrophy, the toxin is injected directly into the masseter muscles to reduce muscle force and volume, thereby alleviating teeth grinding and associated pain. This specific application is being evaluated in clinical trials by Zonguldak Bulent Ecevit University to compare its efficacy against traditional occlusal splint therapies.

Brand names
BotoxDysportXeominMyobloc
Other names
botulinum neurotoxinBoNT
02

Targets

SNAP25 (Synaptosome-associated protein 25)

Beyond the preview

Go deeper on botulinum toxin (Zonguldak Bülent Ecevit University).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on botulinum toxin (Zonguldak Bülent Ecevit University).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call